Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Thursday broker round-up
26 Jul 2018 - Countryside's completions boosted by Westleigh acquisition
26 Jul 2018 - Countryside Properties Total Completions Rise As Westleigh Bears Fruit
26 Jul 2018 - Wednesday broker round-up
25 Jul 2018 - UK Earnings, Trading Statements Calendar - Next 7 Days
19 Jul 2018 - Countryside Properties And Sigma Capital Extend Partnership
19 Jun 2018 - Countryside Properties Interim Performance In Line With Expectations
17 May 2018 - UK Earnings, Trading Statements Calendar - Next 7 Days
10 May 2018
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Thursday broker round-up
(Sharecast News) - Beazley: Berenberg upgrades to buy with a target price of 640p.
Countryside's completions boosted by Westleigh acquisition
(Sharecast News) - Housebuilder Countryside Properties increased house completions 27% in the three months to 30 June, boosted by the acquisition of L...
Countryside Properties Total Completions Rise As Westleigh Bears Fruit
LONDON (Alliance News) - Countryside Properties PLC on Thursday reported a surge in total completions in the third quarter of its financial year, as t...
Wednesday broker round-up
(Sharecast News) - Unite Group: Numis downgrades to hold with a target price of 900p.
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 20 July Acacia MiningHalf Year Results BeazleyHalf Year GroupTrading
Countryside Properties And Sigma Capital Extend Partnership
LONDON (Alliance News) - FTSE 250-listed home builder Countryside Properties PLC said Tuesday it extended its partnership with Sigma Capital Group PLC...
Countryside Properties Interim Performance In Line With Expectations
LONDON (Alliance News) - FTSE 250-listed housebuilder Countryside Properties PLC said on Thursday it traded in line with expectations in the first hal...
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 11 May BBA AviationTrading Statement Monday 14 Year Year Year Year 15 Year 16
Follow the stocks
